Ceasing regular physical activity impairs glycemic control Acute transitions to inactive lifestyles disrupt control of bloodstream sugar levels79 million American adults have prediabetes and will likely develop diabetes later on in life, according to the Centers for Disease Control and Prevention. As the true number of people diagnosed with diabetes continues to grow, researchers are focusing on finding why the prevalence of the condition is raising. John Thyfault, an assistant professor in MU’s departments of Diet and Exercise Physiology and Internal Medicine, has discovered that ceasing regular physical activity impairs glycemic control , suggesting that inactivity may play a key role in the development of type 2 diabetes journal médical .
Caution over monoclonal antibody treatment for MS By Sally Robertson, medwireNews Reporter Alemtuzumab, an anti-CD52 monoclonal antibody, offers a even more effective treatment for folks with relapsing-remitting multiple sclerosis than the immunomodulating drug interferon beta 1a, but has significant side effects, show findings from a stage III trial. Related StoriesJanssen indicators license contract with Alligator Bioscience for immuno-oncology antibodyNew Histone Antibody Specificity Database allows scientists to find correct antibodies for biomedical researchG7 Therapeutics, MorphoSys collaborate on novel antibody therapeutics targeting GPCRs and ion channelsOf 1089 patients randomly assigned to the therapies, the price of relapse was 22 percent among patients who received alemtuzumab, compared with 40 percent among those that received the interferon.